on Jaguar Health, Inc. (NASDAQ:JAGX)
Jaguar Health to Present at Life Sciences Virtual Investor Forum
Jaguar Health, Inc. announced that CEO Lisa Conte will present at the Life Sciences Virtual Investor Forum on June 24, 2026. The company, listed on NASDAQ as JAGX, will discuss updates on its Crofelemer development program for managing rare intestinal failure diseases.
Part of the presentation will cover two studies involving Crofelemer in pediatric patients with microvillus inclusion disease (MVID) and short bowel syndrome (SBS-IF). These studies will also be featured at the European Society for Pediatric Gastroenterology, Hepatology & Nutrition Meeting from June 24-27, 2026.
Jaguar Health specializes in the development of plant-based prescription drugs for complex gastrointestinal conditions. It collaborates with Napo Pharmaceuticals and Napo Therapeutics to commercialize treatments.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Jaguar Health, Inc. news